Health
This company could take lab-grown meat mainstream thanks to a green light from the FDA
A look at Upside’s prepared chicken product. Upside Foods When Amy Chen took her first bite of chicken meat grown directly from cells in a lab, her initial reaction was a cliché one-liner: It tasted like chicken. That bite was years in the making. Chen is the operating chief at Upside Foods, a Berkeley, California-based […]
Read More
FDA advisors recommend Pfizer’s RSV vaccine for infants but raise safety concerns
Respiratory syncytial virus – viral vaccine under research Hailshadow | Istock | Getty Images The Food and Drug Administration’s independent panel of advisors on Thursday recommended full approval of Pfizer’s vaccine that protects infants from RSV, but raised safety concerns over premature births that may be tied to the shot. The committee unanimously said the […]
Read More
CDC urges mpox vaccination among people at high risk to prevent summer surge
Bottle of Vaccine for booster shot for Smallpox and Monkeypox MPXV. Angelp | Istock | Getty Images The Centers for Disease Control and Prevention on Thursday urged gay men and other individuals at high risk from mpox to get fully vaccinated to prevent a summer resurgence of the virus. The CDC’s call for those at […]
Read More
Horizon Therapeutics says Amgen deal could close earlier than planned if FTC fails to block it
Robert Galbraith | Reuters Horizon Therapeutics expects its $27.8 billion sale to Amgen to close as early as the end of the third quarter, earlier than previously planned — if the Federal Trade Commission’s attempt to block the deal fails — according to a document filed Thursday with the Securities and Exchange Commission. The FTC […]
Read More
Neuralink competitor Paradromics gets one step closer to FDA approval for its brain implant
Paradromics Cortical Module Source: Padromics A fast-growing team of nearly 50 scientists and engineers at the neurotech startup Paradromics has captured the attention of federal regulators. Paradromics, founded in 2015, is developing a brain implant that could help patients with severe paralysis regain their ability to communicate by deciphering their neural signals. And on Thursday, […]
Read More
We’re starting a new position in one of the Big 3 global medical imaging and diagnostics companies
This company operates in an $84 billion total addressable market that the company sees growing to around $100 billion by 2024. Source
Read More
Pfizer to raise $31 billion in debt offering to fund Seagen acquisition, SEC filing shows
A logo for Pfizer is displayed on a monitor on the floor at the New York Stock Exchange, July 29, 2019. Brendan McDermid | Reuters Pfizer plans to raise $31 billion through a debt offering to fund its proposed acquisition of cancer drugmaker Seagen, for what would be its largest takeover since 2009, according to […]
Read More
Access to abortion pill mifepristone at stake in federal appeals court hearing
Mifepristone, the first medication in a medical abortion, is prepared for a patient at Alamo Women’s Clinic in Carbondale, Illinois, April 20, 2023. Evelyn Hockstein | Reuters A federal appeals court will hear arguments Wednesday afternoon in a closely watched lawsuit that seeks to pull the abortion pill mifepristone from the U.S. market. The hearing […]
Read More
Oppenheimer says investors are missing opportunities in three biotech areas and the related stocks
As biopharma investors follow the latest buzz around advancements in clinical research, they may be under-appreciating opportunities in neurology, psychiatry and genetic medicine, according to a report from Oppenheimer. Specifically, analyst Jay Olson called out companies such as Biogen , Karuna Therapeutics and Crispr Therapeutics , among others. “Our analysis shows Genetic Medicine and Metabolic […]
Read More
Horizon Therapeutics stock plunges on report FTC is preparing to block Amgen deal
Robert Galbraith | Reuters Horizon Therapeutics‘ stock price plunged more than 17% in premarket trading Tuesday after a report that the Federal Trade Commission is preparing to file a lawsuit to block the biotech company’s $27.8 billion sale to Amgen. The FTC could sue to block the acquisition as soon as Tuesday, Bloomberg reported, citing […]
Read More